*/
Rachel Davenport, Co-founder and Director at AlphaBiolabs, discusses the role that drug, alcohol and DNA testing can play in non-court dispute resolution (NCDR)
Changes to the Family Procedure Rules in relation to NCDR, which came into force in April 2024, marked a transformative moment for family law professionals and mediation practices in the UK.
Designed to strengthen the role of mediation by placing emphasis on non-adversarial approaches and broadening the definition of NCDR to include a wide range of methods for dispute resolution, the rules seek to empower families to resolve conflicts constructively, with minimal court intervention.
However, the success of mediation often depends on the trust and cooperation of all parties. In cases involving allegations of substance misuse or disputes over biological relationships, impartial evidence provided by drug, alcohol and DNA testing can help to:
For counsel involved in family law, mediation and child welfare, impartial evidence from drug, alcohol and DNA testing has become an indispensable tool for facilitating informed decisions.
Drug, alcohol and/or DNA testing may be sought during NCDR for a variety of reasons including:
The results of these tests can provide legal practitioners with concrete evidence needed to navigate disputes, strengthen mediation outcomes, and meet court-mandated evidence standards when NCDR is pursued.
Concerns surrounding a parent’s suspected substance misuse can heavily impact mediation where the issues of childcare and visitation are central to discussions. In these circumstances, drug and alcohol tests offer impartial evidence as to whether or not there has been recent or longer-term substance misuse.
Options for testing include:
These methods ensure that decisions about parenting arrangements can be made based on objective evidence, prioritising the child/children’s welfare.
Uncertainty surrounding a child’s parentage can cause significant emotional strain during mediation, leading to emotionally-charged discussions that dominate proceedings.
In these circumstances, DNA testing such as paternity testing or non-invasive prenatal paternity testing – which can be performed from as early as 7 weeks into pregnancy, and is completely risk-free for mum and baby – can offer a simple, accurate and reliable way of confirming a child’s parentage.
This can allow separating families to reach decisions more quickly regarding visitation and custody arrangements, as well as financial support.
The NCDR rules highlight the importance of open communication and co-operation in resolving family disputes, and helping families to reach agreements based on trust and clarity.
Whether testing is required to ensure a child’s safety or to confirm a biological relationship, AlphaBiolabs can help.
We have over 20 years’ experience providing drug, alcohol and DNA testing for legal and official matters, including as part of NCDR.
We also provide rapid results from our UKAS 17025-acredited UK laboratory, with all testing performed in the UK – so samples are never sent abroad.
For more information contact our New Enquiry team on 0333 600 1300 / testing@alphabiolabs.com or visit https://www.alphabiolabs.co.uk/legal-test-forms/, and we will be happy to discuss the requirements of your case.
Changes to the Family Procedure Rules in relation to NCDR, which came into force in April 2024, marked a transformative moment for family law professionals and mediation practices in the UK.
Designed to strengthen the role of mediation by placing emphasis on non-adversarial approaches and broadening the definition of NCDR to include a wide range of methods for dispute resolution, the rules seek to empower families to resolve conflicts constructively, with minimal court intervention.
However, the success of mediation often depends on the trust and cooperation of all parties. In cases involving allegations of substance misuse or disputes over biological relationships, impartial evidence provided by drug, alcohol and DNA testing can help to:
For counsel involved in family law, mediation and child welfare, impartial evidence from drug, alcohol and DNA testing has become an indispensable tool for facilitating informed decisions.
Drug, alcohol and/or DNA testing may be sought during NCDR for a variety of reasons including:
The results of these tests can provide legal practitioners with concrete evidence needed to navigate disputes, strengthen mediation outcomes, and meet court-mandated evidence standards when NCDR is pursued.
Concerns surrounding a parent’s suspected substance misuse can heavily impact mediation where the issues of childcare and visitation are central to discussions. In these circumstances, drug and alcohol tests offer impartial evidence as to whether or not there has been recent or longer-term substance misuse.
Options for testing include:
These methods ensure that decisions about parenting arrangements can be made based on objective evidence, prioritising the child/children’s welfare.
Uncertainty surrounding a child’s parentage can cause significant emotional strain during mediation, leading to emotionally-charged discussions that dominate proceedings.
In these circumstances, DNA testing such as paternity testing or non-invasive prenatal paternity testing – which can be performed from as early as 7 weeks into pregnancy, and is completely risk-free for mum and baby – can offer a simple, accurate and reliable way of confirming a child’s parentage.
This can allow separating families to reach decisions more quickly regarding visitation and custody arrangements, as well as financial support.
The NCDR rules highlight the importance of open communication and co-operation in resolving family disputes, and helping families to reach agreements based on trust and clarity.
Whether testing is required to ensure a child’s safety or to confirm a biological relationship, AlphaBiolabs can help.
We have over 20 years’ experience providing drug, alcohol and DNA testing for legal and official matters, including as part of NCDR.
We also provide rapid results from our UKAS 17025-acredited UK laboratory, with all testing performed in the UK – so samples are never sent abroad.
For more information contact our New Enquiry team on 0333 600 1300 / testing@alphabiolabs.com or visit https://www.alphabiolabs.co.uk/legal-test-forms/, and we will be happy to discuss the requirements of your case.
Rachel Davenport, Co-founder and Director at AlphaBiolabs, discusses the role that drug, alcohol and DNA testing can play in non-court dispute resolution (NCDR)
The Chair of the Bar reports back
Clement Cowley, Partner at The Penny Group, explains how global events can influence the performance of pensions and ISAs, and why taking a long-term approach to investing is often the most effective strategy
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, discusses what family law professionals need to know about hallucinogens, from the main hallucinogenic drugs encountered in family proceedings, to their effects and the testing options available
Harmony Christian Ministries is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
Developing a tech start-up demands a different definition of excellence to the Bar, says Saara Idelbi. The co-creator of Advocatr on entrepreneurship, AI advocacy training, and matching the thrill of a killer cross-examination
At the start of her term, Chair of the Bar 2026 Kirsty Brimelow KC set out a series of priorities for the year ahead. One of those priorities was children in the justice system
As the world becomes more digital, Barbara Vinagre Mota examines international research into the mental health consequences of judges’ exposure to graphic and immersive evidence, highlighting the importance of support systems
Reviewed by Daniel Barnett
James McNeill Whistler at Tate Britain until 27 September Rothko in Florence at Palazzo Strozzi until 23 August Reviewed by Stephen Cragg KC